HOXB8 and cancer: Additionally, in colorectal cancer (CRC), miR-196 could lead to metastasis by inhibiting HoxB8, and it can also decrease the sensitivity of cancer cells to chemotherapy with FOLFOX4, resulting in unfavorable prognosis [49], supporting it is a favorable prognostic biomarker.